Biomea Fusion (BMEA) Plunges in Afterhours Following FDA Clinical Hold
Biomea Fusion, Inc. (NASDAQ: BMEA) endured a tumultuous day on Thursday, with its shares plummeting nearly 5%. However, the real blow came after hours, as the stock nosedived an additional 60%, trading as low as $4.65 by late Thursday evening, a stark contrast to its morning opening at $11.80. Drastic FDA Decision for Biomea This […]
Biomea Fusion (BMEA) Plunges in Afterhours Following FDA Clinical Hold Read More »